Induction of the ABC-transporters Mdr1/P-gp (Abcb1), mrpl (Abcc1), and bcrp (Abcg2) during establishment of multidrug resistance following exposure to mitoxantrone (Q40416245)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Induction of the ABC-transporters Mdr1/P-gp (Abcb1), mrpl (Abcc1), and bcrp (Abcg2) during establishment of multidrug resistance following exposure to mitoxantrone	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Induction of the ABC-transporters Mdr1/P-gp (Abcb1), mrpl (Abcc1), and bcrp (Abcg2) during establishment of multidrug resistance following exposure to mitoxantrone (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

multiple drug resistance

1 reference

based on heuristic

inferred from title

author name string

C Nieth

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

H Lage

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

publication date

1 April 2005

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Journal of Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

215-223

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Phase I clinical trial f mitoxantrone: a new anthracenedione anticancer drug

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.2.215

21 January 2018

Rationale for the use of mitoxantrone in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.2.215

21 January 2018

Multidrug resistance in cancer: role of ATP-dependent transporters

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.2.215

21 January 2018

ABC-transporters: implications on drug resistance from microorganisms to human cancers

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.2.215

21 January 2018

P-glycoprotein: from genomics to mechanism.

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.2.215

21 January 2018

The MRP family of drug efflux pumps

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.2.215

21 January 2018

Effect of the breast-cancer resistance protein on atypical multidrug resistance

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.2.215

21 January 2018

The reversal of multidrug resistance: an update

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.2.215

21 January 2018

Multidrug resistance reversal agents

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.2.215

21 January 2018

Overcoming Multidrug Resistance in Cancer: An Update on the Clinical Strategy of Inhibiting P-Glycoprotein

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.2.215

21 January 2018

Segregation of human hypoxanthine phosphoribosyltransferase activity from somatic cell hybrids isolated after fusion of mouse gene transfer cells with Chinese hamster cells

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.2.215

21 January 2018

Intraspecies transfer via total cellular DNA of the gene for hypoxanthine phosphoribosyltransferase into cultured mouse cells

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.2.215

21 January 2018

Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi).

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.2.215

21 January 2018

Glypican-3 is involved in cellular protection against mitoxantrone in gastric carcinoma cells

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.2.215

21 January 2018

New colorimetric cytotoxicity assay for anticancer-drug screening

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.2.215

21 January 2018

Stable and complete overcoming of MDR1/P-glycoprotein-mediated multidrug resistance in human gastric carcinoma cells by RNA interference

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.2.215

21 January 2018

Multiple mechanisms confer different drug-resistant phenotypes in pancreatic carcinoma cells

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.2.215

21 January 2018

Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.2.215

21 January 2018

Cytogenetic and molecular characterization of random chromosomal rearrangements activating the drug resistance gene, MDR1/P-glycoprotein, in drug-selected cell lines and patients with drug refractory ALL.

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.2.215

21 January 2018

Identifiers

10.1179/JOC.2005.17.2.215

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40416245&oldid=1897283677"